References
- Degli EspostiLValpianiGPharmacoeconomic burden of undertreating hypertensionPharmacoeconomics2004221490792815362928
- RobbianoLMartelliABrambillaGDiscrepancies between use of antihypertensive drugs and guidelines indications: Pharmacoeconomic implicationsJ Hum Hypertens2005191081982215951739
- The use of pharmaceuticals in Italy. National Report 2007RomeIl Pensiero Scientifico Editore2008
- PsatyBMLumleyTFurbergCDHealth outcomes associated with various antihypertensive therapies used as first-line agents: A network meta analysisJAMA2003289192534254412759325
- TurnbullFBlood Pressure Lowering Treatment Trialists’ CollaborationEffects of different blood pressure lowering regimens on major cardiovascular events: Second cycle of prospectively designed overviewsLancet200393953621527153514615107
- ChalmersJComparison of various blood pressure lowering treatments on the primary prevention of cardiovascular outcomes in recent randomised clinical trialsClin Exp Hypertens2004267–870971915702625
- TurnbullFNealBNinomiyaTEffects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomised trials. Blood Pressure Lowering Treatment Trialists’ CollaborationBMJ200833676531121122318480116
- RasmussenJNChongAAlterDARelationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarctionJAMA2007297217718617213401
- HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med2006166171836184117000939
- HoPMSpertusJAMasoudiFAImpact of medication therapy discontinuation on mortality after myocardial infarctionArch Intern Med2006166171842184717000940
- SokolMCMcGuiganKAVerbruggeRRImpact of medication adherence on hospitalization risk and healthcare costMed Care200543652153015908846
- KettaniFZDragomirACotéRImpact of a better adherence to antihypertensive agents on cerebrovascular disease for primary preventionStroke200940121322019038916
- MazzagliaGAmbrosioniEAlacquaMAdherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patientsCirculation2009120161598160519805653
- Degli EspostiLDegli EspostiEValpianiGA retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in ItalyClin Ther20022481347135712240784
- Degli EspostiLDi MartinoMSaragoniSPharmacoeconomics of antihypertensive drug treatment: An analysis of how long patients remain on various antihypertensive therapiesJ Clin Hypertens2004627684
- Degli EspostiESturaniADi MartinoMLong-term persistence with antihypertensive drugs in new patientsJ Hum Hypertens200216643944412037702
- CaroJJSalasMSpeakmanJLPersistence with treatment for hypertension in actual practiceCan Med Assoc J1999160137
- MazzagliaGMantovaniLSturkenboomMCPatterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary careJ Hypertens200523112093210016208153
- CorraoGZambonAParodiADiscontinuation of and changes in drug therapy for hypertension among newly-treated patients: A population-based study in ItalyJ Hypertens20082648192418327094
- Breekveldt-PostmaNPenning-van BeestFSiiskonenSThe effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and strokeCurr Med Res Opin200824112112718031596
- CatalanVSLeLorierJPredictors of long-term persistence on statins in a subsidized clinical populationValue Health20003641742616464201
- PerreaultSDragomirAWhiteMLalondeLBlaisLBérardABetter adherence to antihypertensive agents and risk reduction of chronic heart failureJ Intern Med2009266220721819623691
- Degli EspostiLDi MartinoMSaragoniSCaponeARussoPDegli EspostiECost offset of lipid-lowering drugs for primary and secondary prevention of cardiovascular diseaseExpert Rev Pharmacoecon Outcomes Res20055219320519807574
- BaioGEspostiLDEspostiEDBayesian cost-effectiveness analysis based on the persistence with antihypertensive treatmentExpert Rev Pharmacoecon Outcomes Res20033322723619807371
- KotsevaKWoodDDe BackerDfor the EUROASPIRE Study GroupCardiovascular prevention guidelines in daily practice: Comparison of EUROASPIRE I, II, and III surveys in eight European countriesLancet2009373966792994019286092
- GazianoTABittonAAnandSThe global cost of non optimal blood pressureJ Hypertens2009271472719474763
- World Health OrganizationAdherence to long-term therapiesEvidence for actionGenevaWorld Health Organization2003
- MotheralBRFairmanKAThe use of claims databases for anti-hypertensive drugs and associated hospitalizationClin Ther19971923463669152572
- BirnbaumHGCremieuxPYGreenbergPEUsing health care expenditures for healthcare claims data for outcome research and pharmaco-economic analysesPharmacoeconomics1999161810539118